A detailed history of Koshinski Asset Management, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Koshinski Asset Management, Inc. holds 10,671 shares of RPRX stock, worth $276,165. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,671
Previous 14,550 26.66%
Holding current value
$276,165
Previous $408,000 20.59%
% of portfolio
0.03%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$27.46 - $31.33 $106,517 - $121,529
-3,879 Reduced 26.66%
10,671 $324,000
Q4 2023

Jan 29, 2024

BUY
$26.21 - $29.22 $83,347 - $92,919
3,180 Added 27.97%
14,550 $408,000
Q3 2023

Oct 18, 2023

SELL
$26.26 - $31.38 $40,177 - $48,011
-1,530 Reduced 11.86%
11,370 $308,000
Q2 2023

Jul 28, 2023

SELL
$29.6 - $36.56 $32,560 - $40,216
-1,100 Reduced 7.86%
12,900 $396,000
Q4 2022

Jan 24, 2023

BUY
$39.17 - $44.04 $548,380 - $616,560
14,000 New
14,000 $0

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.3B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.